Brief: Sedana Medical Q1 Sales SEK 53.4 Million
23/04/2026 06:00
Apr 23 (Reuters) - Sedana Medical Q1 EBITDA SEK 1.8 million. Q1 adjusted EPS SEK -0.04 Q1 net income SEK -3.7 million Q1 EBIT margin -11% Q1 cash flow from operating activities SEK 2.7 million
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln